Разработка и регистрация лекарственных средств

LLC Center of Pharmaceutical Analytics (LLC «CPHA»)

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Разработка и регистрация лекарственных средств is an open-access journal published by LLC Center of Pharmaceutical Analytics (LLC «CPHA») in Russia, publishing in russian. It is listed in DOAJ according to the sources read. Declared publication charge: 49,000 RUB. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
ISSN
2305-2066 · 2658-5049
Country
Russia
Languages
russian
Access
Open access
Declared publication charge
49,000 RUB
Articles in DOAJ
1121
Declared review time
8 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2020-05-10
Indexing
DOAJ
APC
49,000 RUB
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1121

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

918

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

10

i10-index

15

From OpenAlex open data (CC0).

Editorial & policy9
Last DOAJ review date
2026-06-24
Added to DOAJ
2020-05-10
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
99%
ORCID iDs in current deposits
99%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Alternate titles
Drag development & registration
Source type
journal
Classification2

Subjects (DOAJ)

Social Sciences: Industries. Land use. Labor: Special industries and trades: Pharmaceutical industry

LCC codes

HD9665-9675

Subject areas

  • Pharmacological Effects of Natural Compounds
  • Pharmacological Effects of Natural Compounds
  • Medicinal plant effects and applications
  • Medicinal plant effects and applications
  • Drug Solubulity and Delivery Systems
  • Drug Solubulity and Delivery Systems
  • Analytical Chemistry and Chromatography
  • Analytical Chemistry and Chromatography
Show all subjects (50)
  • Neurological Disorders and Treatments
  • Phytochemical and Pharmacological Studies
  • Neurological Disorders and Treatments
  • Phytochemicals and Antioxidant Activities
  • Phytochemicals and Antioxidant Activities
  • Phytochemical and Pharmacological Studies
  • Synthesis and biological activity
  • Synthesis and biological activity
  • Analytical Methods in Pharmaceuticals
  • Analytical Methods in Pharmaceuticals
  • Protein purification and stability
  • Protein purification and stability
  • Phytochemistry and Biological Activities
  • Phytochemistry and Biological Activities
  • Polymer Synthesis and Characterization
  • Polymer Synthesis and Characterization
  • Natural product bioactivities and synthesis
  • Natural product bioactivities and synthesis
  • Chromatography in Natural Products
  • Chromatography in Natural Products
  • Advanced Drug Delivery Systems
  • Chemical synthesis and pharmacological studies
  • Chemical synthesis and pharmacological studies
  • Economic, Social, and Public Health Issues in Russia and Globally
  • Advanced Drug Delivery Systems
  • Economic, Social, and Public Health Issues in Russia and Globally
  • Synthesis and Characterization of Heterocyclic Compounds
  • Synthesis and Characterization of Heterocyclic Compounds
  • Crystallization and Solubility Studies
  • Crystallization and Solubility Studies
  • Drug-Induced Hepatotoxicity and Protection
  • Essential Oils and Antimicrobial Activity
  • Essential Oils and Antimicrobial Activity
  • Drug-Induced Hepatotoxicity and Protection
  • Biosimilars and Bioanalytical Methods
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Synthesis and Reactions of Organic Compounds
  • Biochemical effects in animals
  • Biosimilars and Bioanalytical Methods
  • Medicinal Plants and Bioactive Compounds
  • Biochemical effects in animals

Keywords (DOAJ)

  • acute toxicity
  • antimicrobial activity
  • bioavailability
  • bioequivalence
  • clinical trials
  • drugs

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: